Coronary CT angiography and high-risk plaque morphology

Cardiovascular Intervention and Therapeutics

Volumn 28, Issue 1, 2013, Pages 1-8

  Motoyama, Sadako ^a   Sarai, Masayoshi ^a   Narula, Jagat ^b   Ozaki, Yukio ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Coronary computed tomography angiography; High risk plaque

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY PLAQUE; HIGH RISK PATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 84873629863     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-012-0140-1     Document Type: Review

References (49)

1. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation. 2008; 118: 586-606.
2. Raff GL, Abidov A, Achenbach S, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009; 3: 122-36.
3. Davies MJ. The composition of coronary-artery plaques. N Engl J Med. 1997; 336: 1312-4.
4. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336: 1276-82.
5. Narula J, Finn AV, Demaria AN. Picking plaques that pop. J Am Coll Cardiol. 2005; 45: 1970-3.
6. Narula J, Willerson JT. Prologue: detection of vulnerable plaque. J Am Coll Cardiol. 2006; 47: C1.
7. Muller JE, Tawakol A, Kathiresan S, Narula J. New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques. J Am Coll Cardiol. 2006; 47: C2-6.
8. Hassani S-E, Mintz GS, Fong HS, et al. Negative remodeling and calcified plaque in octogenarians with acute myocardial infarction: an intravascular ultrasound analysis. J Am Coll Cardiol. 2006; 47: 2413-9.
9. Maehara A, Mintz GS, Bui AB, et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol. 2002; 40: 904-10.
10. Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004; 110: 3424-9.
11. Sano K, Kawasaki M, Ishihara Y, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2006; 47: 734-41.
12. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111: 1551-5.
13. Stamper D, Weissman NJ, Brezinski M. Plaque characterization with optical coherence tomography. J Am Coll Cardiol. 2006; 47: C69-79.
14. Schneiderman J, Wilensky RL, Weiss A, et al. Diagnosis of thin-cap fibroatheromas by a self-contained intravascular magnetic resonance imaging probe in ex vivo human aortas and in situ coronary arteries. J Am Coll Cardiol. 2005; 45: 1961-9.
15. Wilensky RL, Song HK, Ferrari VA. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J Am Coll Cardiol. 2006; 47: C48-56.
16. Toutouzas K, Drakopoulou M, Mitropoulos J, et al. Elevated plaque temperature in non-culprit de novo atheromatous lesions of patients with acute coronary syndromes. J Am Coll Cardiol. 2006; 47: 301-6.
17. Madjid M, Willerson JT, Casscells SW. Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol. 2006; 47: C80-5.
18. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation. 2000; 101: 598-603.
19. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation. 2003; 108: 1772-8.
20. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007; 50: 319-26.
21. Inoue F, Sato Y, Matsumoto N, et al. Evaluation of plaque texture by means of multislice computed tomography in patients with acute coronary syndrome and stable angina. Circ J. 2004; 68: 840-4.
22. Imazeki T, Sato Y, Inoue F, Anazawa T, Tani S, Matsumoto N, et al. Evaluation of coronary artery remodeling in patients with acute coro-nary syndrome and stable angina by multislice computed tomogra-phy. Circ J. 2004; 68(1045-1050): 30.
23. Hoffmann U, Moselewski F, Nieman K, et al. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol. 2006; 47: 1655-62.
24. Tanaka A, Shimada K, Yoshida K, et al. Non-invasive assessment of plaque rupture by 64-slice multidetector computed tomography-comparison with intravascular ultrasound. Circ J. 2008; 72: 1276-81.
25. Shapiro E, Bush D, Motoyama S, Virmani R, Narula J. Imaging of vulnerable atherosclerotic plaques. In: Budoff M, Achenbach S, Narula J, editors. Atlas of cardiovascular computed tomography. Philadelphia: Current Medicine Group LLC; 2007. p. 119-38.
26. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med. 2008; 5(Suppl 2): S2-10.
27. Motoyama S, Sarai M, Harigaya H, et al. Computed tomograpiographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009; 54: 49-57.
28. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006; 47: C101-3.
29. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-47.
30. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347: 1557-65.
31. Braunwald E. Noninvasive detection of vulnerable coronary plaques: locking the barn door before the horse is stolen. J Am Coll Cardiol. 2009; 54: 58-9.
32. Motoyama S, Anno H, Sarai M, et al. Noninvasive coronary angiography with a prototype 256-row area detector computed tomography system: comparison with conventional invasive coronary angiography. J Am Coll Cardiol. 2008; 51: 773-5.
33. Rybicki FJ, Otero HJ, Steigner ML, et al. Initial evaluation of coronary images from 320-detector row computed tomography. Int J Cardiovasc Imag. 2008; 24: 535-46.
34. Husmann L, Valenta I, Gaemperli O, et al. Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating. Eur Heart J. 2008; 29: 191-7.
35. Achenbach S, Anders K, Kalender WA. Dual-source cardiac computed tomography: image quality and dose considerations. Eur Radiol. 2008; 18: 1188-98.
36. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344: 1383-9.
37. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996; 335: 1001-9.
38. Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS). Am J Cardiol. 2002; 90: 731-6.
39. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359: 2195-207.
40. Tung P, Wiviott SD, Cannon CP, Murphy SA, McCabe CH, Gibson CM. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of pravastatin (40 mg) or atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] Study). Am J Cardiol 2009; 103: 1056-60.
41. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004; 291: 1071-80.
42. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295: 1556-65.
43. Hiro T, Kimura T, Morimoto T, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol. 2009; 54: 293-302.
44. Rodriguez-Granillo GA, de Winter S, Bruining N, Ligthart JM. EUROPA/PERSPECTIVE: investigators. effect of perindopril on coronary remodelling: insights from a multicentre, randomized study. Eur Heart J. 2007; 28: 2326-31.
45. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation. 2006; 113: 2826-34.
46. Fujimoto S, Hartung D, Ohshima S, et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol. 2008; 52: 1847-57.
47. Inoue K, Motoyama S, Sarai M, et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imag. 2010; 3: 691-8.
48. Achenbach S, Ropers D, Hoffmann U, et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol. 2004; 43: 842-7.
49. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol. 47: 672-7.